Oric Pharmaceuticals, Inc.

1. 01

   Behind SPY and its sector fund XLV over 1 year

   1 month: −22.0% (SPY −1.6%, XLV +13.5%). 3 months: −27.8% (SPY −0.4%, XLV +15.5%). 1 year: −24.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: ORIC, SPY and XLV · as of 4 Nov 2026

2. 02

   Below its 50- and 200-day averages

   The 4 Nov 2026 close of $9.34 was 23.4% below its 50-day average ($12.19) and 15.9% below its 200-day average ($11.10). It has closed below the 200-day for 8 sessions, since 26 Oct 2026. The 50-day average crossed above the 200-day on 14 Aug 2026, 57 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

3. 03

   10.5 days to cover short interest

   15.4M shares were sold short at the 15 Oct 2026 settlement, 14.9% of the 103.7M shares outstanding; covering them would take 10.5 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

4. 04

   28% of the way up its 52-week range

   Closed at $9.34 on 4 Nov 2026: 36.4% below the 52-week high of $14.68 (19 Aug 2026) and 29.2% above the low of $7.23 (2 Apr 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

5. 05

   Volume 1.5× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 3.0M shares was 1.5× the average of the 30 sessions before it (1.9M), as the price fell 2.6%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

At the 4 Nov 2026 close